A systematic study on the utility of CHX-A’’-DTPA-NCS and NOTA-NCS as bifunctional chelators for 177 Lu radiopharmaceuticalsUsha Pandey, Ashutosh Dash, Naresh Gamre et al.|Applied Radiation and Isotopes|2017Cited by 17
Preparation of 177Lu-Trastuzumab injection for treatment of breast cancerMythili Kameswaran, Ashutosh Dash, Usha Pandey et al.|Applied Radiation and Isotopes|2019Cited by 17
A systematic evaluation of the potential of PCTA-NCS ligand as a bifunctional chelating agent for design of 177Lu radiopharmaceuticalsUsha Pandey, Ashutosh Dash, Haladhar Dev Sarma et al.|Journal of Radioanalytical and Nuclear Chemistry|2015Cited by 16
Evaluation of 177Lu-CHX-A′′-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancersMythili Kameswaran, Ashutosh Dash, Usha Pandey et al.|Applied Radiation and Isotopes|2016Cited by 12
Preparation of <sup>177</sup>Lu‐labeled Nimotuzumab for radioimmunotherapy of EGFR‐positive cancers: Comparison of DOTA and CHX‐A″‐DTPA as bifunctional chelatorsUsha Pandey, Ashutosh Dash, Mythili Kameswaran et al.|Journal of Labelled Compounds and Radiopharmaceuticals|2019Cited by 10